The content is available as a PDF (129.3 KB).
letter . 2020 Apr 21:hcaa138. doi: 10.1093/qjmed/hcaa138
Response letter to Eosinophil count in severe coronavirus disease 2019 (COVID-19)
Guo-Qing Qian
h1,✉, Xie Zhang
h2, Ada Hoi Yan Ma
h3, Nai-Bin Yang
h1
Guo-Qing Qian
h1Department of General Internal Medicine, Ningbo City First Hospital, Ningbo, Zhejiang Province, China
Find articles by Guo-Qing Qian
Xie Zhang
h2Department of Respiratory Medicine, Yueqing People’s Hospital, Wenzhou, Zhejiang Province, China
Find articles by Xie Zhang
Ada Hoi Yan Ma
h3
Nottingham University Business School, University of Nottingham Ningbo China, Ningbo, Zhejiang Province, China
Find articles by Ada Hoi Yan Ma
Nai-Bin Yang
h1Department of General Internal Medicine, Ningbo City First Hospital, Ningbo, Zhejiang Province, China
Find articles by Nai-Bin Yang
h1Department of General Internal Medicine, Ningbo City First Hospital, Ningbo, Zhejiang Province, China
h2Department of Respiratory Medicine, Yueqing People’s Hospital, Wenzhou, Zhejiang Province, China
h3
Nottingham University Business School, University of Nottingham Ningbo China, Ningbo, Zhejiang Province, China
✉
Name and Address for correspondence: Corresponding Author: Guo-Qing Qian, Address: Department of General Internal Medicine, Ningbo First Hospital, No. 59 Liuting Street, Haishu District, Ningbo, Zhejiang Province, China, 315010, Email: bill.qian@outlook.com
Received 2020 Mar 26; Accepted 2020 Mar 27.
Keywords: eosinopenia, eosinophil count, COVID-19, infectious diseases
© The Author(s) 2020. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oup.com
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7188165 PMID: 32315421
See "Eosinophil count in severe coronavirus disease 2019 (COVID-19)", hcaa137.